293 related articles for article (PubMed ID: 19519384)
21. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
[TBL] [Abstract][Full Text] [Related]
22. Metal-based inhibitors of protein tyrosine phosphatases.
Lu L; Zhu M
Anticancer Agents Med Chem; 2011 Jan; 11(1):164-71. PubMed ID: 21269257
[TBL] [Abstract][Full Text] [Related]
23. Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.
Iversen LF; Andersen HS; Møller KB; Olsen OH; Peters GH; Branner S; Mortensen SB; Hansen TK; Lau J; Ge Y; Holsworth DD; Newman MJ; Hundahl Møller NP
Biochemistry; 2001 Dec; 40(49):14812-20. PubMed ID: 11732900
[TBL] [Abstract][Full Text] [Related]
24. A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis.
Adams J; Thornton BP; Tabernero L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830087
[TBL] [Abstract][Full Text] [Related]
25. Allele-specific inhibition of divergent protein tyrosine phosphatases with a single small molecule.
Zhang XY; Chen VL; Rosen MS; Blair ER; Lone AM; Bishop AC
Bioorg Med Chem; 2008 Sep; 16(17):8090-7. PubMed ID: 18678493
[TBL] [Abstract][Full Text] [Related]
26. CuAAC click chemistry accelerates the discovery of novel chemical scaffolds as promising protein tyrosine phosphatases inhibitors.
He XP; Xie J; Tang Y; Li J; Chen GR
Curr Med Chem; 2012; 19(15):2399-405. PubMed ID: 22455590
[TBL] [Abstract][Full Text] [Related]
27. PTP1B: from the sidelines to the front lines!
Tonks NK
FEBS Lett; 2003 Jul; 546(1):140-8. PubMed ID: 12829250
[TBL] [Abstract][Full Text] [Related]
28. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
He R; Zeng LF; He Y; Zhang S; Zhang ZY
FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
[TBL] [Abstract][Full Text] [Related]
29. Covalent inhibition of protein tyrosine phosphatases.
Ruddraraju KV; Zhang ZY
Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
[TBL] [Abstract][Full Text] [Related]
30. Proteomic approaches to studying protein tyrosine phosphatases.
Liang F; Kumar S; Zhang ZY
Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
[TBL] [Abstract][Full Text] [Related]
31. Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.
Vidović D; Schürer SC
J Med Chem; 2009 Nov; 52(21):6649-59. PubMed ID: 19810703
[TBL] [Abstract][Full Text] [Related]
32. Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases.
Hendriks W; Bourgonje A; Leenders W; Pulido R
Molecules; 2018 Feb; 23(2):. PubMed ID: 29439552
[TBL] [Abstract][Full Text] [Related]
33. Use of Dominant-Negative/Substrate Trapping PTP Mutations to Search for PTP Interactors/Substrates.
Radha V
Methods Mol Biol; 2016; 1447():243-65. PubMed ID: 27514810
[TBL] [Abstract][Full Text] [Related]
34. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
Barr AJ; Knapp S
Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
[TBL] [Abstract][Full Text] [Related]
35. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
Schmidt MF; Groves MR; Rademann J
Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
[TBL] [Abstract][Full Text] [Related]
36. High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators.
Mattila E; Ivaska J
Anticancer Agents Med Chem; 2011 Jan; 11(1):141-50. PubMed ID: 21288196
[TBL] [Abstract][Full Text] [Related]
37. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
Bishop AC; Blair ER
Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
[TBL] [Abstract][Full Text] [Related]
38. Targeting PTPs with small molecule inhibitors in cancer treatment.
Jiang ZX; Zhang ZY
Cancer Metastasis Rev; 2008 Jun; 27(2):263-72. PubMed ID: 18259840
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery.
Elhassan RM; Hou X; Fang H
Med Res Rev; 2022 May; 42(3):1064-1110. PubMed ID: 34791703
[TBL] [Abstract][Full Text] [Related]
40. Small molecule targeting of PTPs in cancer.
Lazo JS; McQueeney KE; Burnett JC; Wipf P; Sharlow ER
Int J Biochem Cell Biol; 2018 Mar; 96():171-181. PubMed ID: 28943273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
